The CDC has signed a $911 million contract to stockpile Emergent BioSolutions' BioThrax.

Tech billionaire Sean Parker’s startup Parker Institute for Cancer Immunotherapy has paired with the legacy Cancer Research Institute to advance development of…

A recently accepted study revived claims that vaccines can cause autism, but, after heavy criticism of the research, the online journal retracted the abstract.

Bavarian Nordic is closer to the finish line in the U.S. with its smallpox vaccine Imvamune.

A team of scientists from Australia is making progress in developing a vaccine that protects the human “surfaces” most likely to encounter the virus first.

Though cancer vaccines have experienced disappointing clinical performance in recent years, their global market as a crucial tool in immunotherapy will grow to…

Years after two late-stage oncology vaccine failures put the field’s future in question, leading companies still believe they can amp up combo regimens.

It’s another silver lining for drugmakers targeting HIV: Researchers have found promise in a combo of a Johnson & Johnson vaccine and a Gilead immune…

In a move that illustrates the stepped-up pace of Zika vaccine development, the Walter Reed Army Institute of Research is moving into human testing for its…

R&D